Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Post by justintime1990on Apr 01, 2021 6:00pm
344 Views
Post# 32925376

Honestly

HonestlyThat presentation sucked this morning. A lot of blood shed would have been prevented if he just stressed that Aristotle was launched and they had made 2.8 million in Q4. His most exciting statement was when he said "exciting times, exciting times here" and it all went down hill from there. His presentation was seemingly deliberately unclear, With any financial saviness, he would know that presentation was not conducive to stock growth to carry forward momentum. Stakeholders should not have to deal with 40% drops in one day, that keeps a lot of investors at bay. They have the right tools, they have the technology, they have good vision, but the way this information is presented is severely lacking. This news release just now said more and gave more confidence than that presentation, and it's released after market on a long weekend!. "Aristotle launched, and we made this much money" that's all I needed to see. This was the chance to knock it out of the park. This isn't bashing, but maybe someone else should be presenting this, a marketer, not a scientist. 
<< Previous
Bullboard Posts
Next >>